PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18678486-0	2008	Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350.	Cyclopentanes	59-71	KRAS proto-oncogene, GTPase	Homo sapiens	131-134	
17845856-0	2007	Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.	Cyclopentanes	82-94	KRAS proto-oncogene, GTPase	Homo sapiens	61-64	
17845856-0	2007	Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.	Cyclopentanes	99-111	KRAS proto-oncogene, GTPase	Homo sapiens	61-64	
17845856-1	2007	Several highly potent novel HCV NS3 protease inhibitors have been developed from two inhibitor series containing either a P2 trisubstituted macrocyclic cyclopentane- or a P2 cyclopentene dicarboxylic acid moiety as surrogates for the widely used N-acyl-(4R)-hydroxyproline in the P2 position.	Cyclopentanes	152-164	KRAS proto-oncogene, GTPase	Homo sapiens	32-35